Navigation Links
Fourth Annual Capitol Classic Bike Race for Autism Awareness
Date:7/22/2009

MINNEAPOLIS and ST. PAUL, Minn., July 22 /PRNewswire-USNewswire/ -- The following was released today by Fraser:

What: Capitol Classic: A Bicycle Ride and Race for Autism Awareness

The Fourth Annual Capitol Classic Charity Bicycle event taking place on the streets surrounding the Minnesota State Capitol. The goal of the Capitol Classic is to raise awareness and funds for autism services provided through Fraser and the Autism Society of Minnesota. Professional cyclists compete for cash prizes while raising awareness for local autism services.

Visual: Come see competitive cyclists biking around the grounds of the beautiful State Capitol. Children of all ages and abilities will join in for the charity race that will include strollers, tricycles and bicycles. Families can enjoy live music, food, biking and a wide variety of children activities, including inflatables, clowns, balloons, face painting and a children's bicycle obstacle course. Mascots and cycling fans from near and far can cheer on the professional cyclists and join in the fun.

When: Sunday, July 26, 2009, 9 a.m. to 4 p.m.

  • 8 a.m. to 4 p.m. Professional level cycling around the Minnesota State Capitol grounds
  • 8 a.m. to 4 p.m. Music
  • 8 a.m. to 4 p.m. Wide variety of food and refreshments including Jamba Juice
  • 10 a.m. to 3 p.m. Minnesota Twins TC Bear mascot
  • 10 a.m. to 3 p.m. Face painting, Balloons, moonwalk and cool clowns.
  • 10 a.m. to 3 p.m. Fun area featuring activities for all ages
  • 10:45 a.m. Charity Fun Ride (all ages, abilities and disabilities)
  • 11:15 a.m. Kids ride (2-10 years-old)

Everyone is encouraged to stay all day to watch several championship level bike races scheduled throughout the event. Free parking and free admission. For more information about race times, registration fees, prizes and donations visit www.bikeforautism.org.

Interviews:

  • Fraser autism experts
  • Jay Dworsky, Event Promoter and father of a son with autism
  • Diane S. Cross, Fraser president and CEO

Where: The streets surrounding Minnesota's State Capitol in St. Paul.

More: Autism is the fastest growing disability in the U.S., 1 in 150 American children is diagnosed with an autism spectrum disorder. Early intervention is extremely important for children with autism. Fraser is a Minnesota nonprofit with a nationally renowned reputation, serving children and adults with special needs. This multi-faceted human service organization provides direct services, information and support in the areas of education, housing and healthcare. Fraser serves children with developmental disabilities; children who are at risk for abuse and neglect; children with autism and severe emotional and behavioral disorders; and adults with developmental disabilities. Fraser is Minnesota's longest-running, largest provider of autism services. For more information, call 612-861-1688 or visit www.fraser.org.

Note to editor: Don't miss competitive cyclists biking past the Minnesota State Capitol building and fun activities for the entire family!


'/>"/>
SOURCE Fraser
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2009 Results
2. Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009
3. Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
4. Americans United for Life Applauds Fourth Circuit Protecting Women and Children by Upholding Virginia Partial Birth Abortion Statute
5. Arcadia Resources Announces Fourth Quarter and Fiscal 2009 Year-End Results
6. Allscripts to Announce Fiscal Fourth Quarter and Year-End Results on July 20, 2009
7. America Speaks Out in Favor of Affordable Healthcare and Biogenerics in Tevas Fourth Video
8. TrinityCare Senior Living Announces Funding Agreement for Fourth Senior Living Facility
9. Give Life for the Fourth of July
10. China Medical Technologies Announces Selected Unaudited Preliminary Financial Results for the Fourth Fiscal Quarter and Full Year Ended March 31, 2009
11. Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: